CoChat

Urinary Eosinophils in AIN: Farewell to an Old Biomarker?

Open access
Perazella, Mark A., Bomback, Andrew S. · 2013 · Clinical Journal of the American Society of Nephrology
Cited by 27

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Urinary biomarkers of kidney injury are an area of ongoing research in nephrology. For years, urinary eosinophils have been used as biomarkers for acute interstitial nephritis (AIN). The characteristics that would make eosinophiluria a useful biomarker for AIN include that (1) eosinophils are consistently present in the urine of patients with AIN (i.e., AIN is characterized by an eosinophilic interstitial infiltrate), (2) eosinophils are absent in the setting of another etiology of AKI (i.e., other renal and extrarenal diseases are not associated with eosinophiluria), and (3) a predetermined percentage of eosinophils is easily visualized in the urine when present (i.e., excellent stain performance). As early as 1967, urinary eosinophils were reported in rejection episodes after kidney transplantation, suggesting that they were associated with “kidney inflammation” (1). The earliest description of this test as a biomarker for AIN was by Galpin et al. (2) in 1978. Using the Wright stain, nine of nine cases of methicillin-associated AIN had urinary eosinophils. Six of nine cases had biopsy-proven AIN, with eosinophils within the renal interstitium and occasionally, tubular lumens; 0 of 43 patients with AKI from another diagnosis had eosinophiluria. These data implied that eosinophiluria was a sensitive and specific test for AIN. Linton et al. (3) subsequently described eosinophiluria in six of nine patients with drug-induced AIN. Eight patients had biopsy-proven AIN, with five patients having prominent interstitial eosinophils. Overall, these two small studies suggested that eosinophiluria might be a reasonably good biomarker for AIN. Additional work on this subject by Corwin et al. (4) examined the clinical correlates of eosinophiluria using the Wright stain in 65 patients. AIN was diagnosed in 9 of 65 patients, with eosinophiluria noted in 8 of 9 of these cases, replicating previous data. However, urinary eosinophils were also shown in 27 of 56 patients with diagnoses other than AIN (Table 1), suggesting that the test was rather nonspecific. Corwin et al. (4) concluded that using a >5% eosinophil cutoff might identify a group with higher probability of having AIN. However, 6 of 56 non-AIN patients and only 4 of 9 AIN patients met this cutoff, which (not unexpectedly) improved specificity but reduced sensitivity. The lack of sensitivity of urinary eosinophils was further emphasized in a review paper based on data from 10 studies examining drug-induced AIN showing that eosinophiluria was present in only 59% (19/32) of biopsy-proven AIN cases (5).Table 1: Urinary eosinophils in the diagnosis of acute interstitial nephritisBecause low sensitivity was the major concern, Nolan et al. (6) renewed interest in eosinophiluria as an AIN biomarker with a New England Journal of Medicine publication that hailed the Hansel stain as a better method to visualize urinary eosinophils. This stain was chosen based on its use in identifying eosinophils in nasal, bronchial, and ocular secretions of patients with allergy-related diseases; 92 patients with an active urine sediment were identified by the nephrology consult service, of which 11 patients had AIN (proven by biopsy in 2 patients). Hansel stain was positive in 10 of 11 AIN cases, whereas Wright stain was positive in only 2 of 11 cases. Hansel stain was also positive in other diagnoses but negative in all 30 acute tubular necrosis cases (Table 1). Overall, the Hansel stain provided a sensitivity of 91% and positive predictive value of 45%. Nolan et al. (6) concluded that the Hansel stain improved the sensitivity of eosinophiluria in AIN but that the test was not specific. Nolan et al. (6) emphasized that it was useful when the differential diagnosis of AKI boiled down to AIN versus acute tubular necrosis. Additionally, Nolan et al. (6) argued that a positive test in the setting of high pretest probability for AIN tends to confirm the diagnosis, whereas negative eosinophiluria in patients with low pretest probability can reasonably exclude AIN. However, lack of biopsy confirmation of AIN was a major flaw of the paper. In the face of these data, a study was undertaken to more completely define the significance of eosinophiluria (7). Urine for eosinophils was examined in 183 patients assigned a clinical diagnosis using blinded chart review, with AIN based on biopsy or clinical diagnosis. Eosinophiluria was documented in 20 patients, with Hansel stain positive in 18 of 20 patients and Wright stain positive in 8 of 20 patients. Hansel and Wright stains were positive in five of eight and two of eight AIN cases, respectively. Clearly, Hansel stain improved urinary eosinophil detection compared with Wright stain, confirming the data in the work by Nolan et al. (6). Although Hansel stain was also positive in other diagnoses, it still had a very good specificity and negative predictive value of 98% (Table 1). Corwin et al. (7) concluded that Hansel stain improved detection of urinar

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2215/cjn.08620813

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

Metadata

Authors
Perazella, M. A., & Bomback, A. S.
Venue
Clinical Journal of the American Society of Nephrology
Published
2013-11
Volume
8
Issue
11
Pages
1841-1843
ISSN
1555-9041 (ISSN-L)
OpenAlex
W2131713587
Cited by
27
References
2
FWCI
0.88
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.